NLIGHT INC (LASR)

US65487K1007 - Common Stock

11.28  +0.28 (+2.55%)

After market: 11.28 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to LASR. LASR was compared to 127 industry peers in the Electronic Equipment, Instruments & Components industry. No worries on liquidiy or solvency for LASR as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, LASR is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

In the past year LASR has reported negative net income.
In the past year LASR had a positive cash flow from operations.
LASR had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: LASR reported negative operating cash flow in multiple years.

1.2 Ratios

LASR's Return On Assets of -13.58% is on the low side compared to the rest of the industry. LASR is outperformed by 69.84% of its industry peers.
LASR's Return On Equity of -16.38% is on the low side compared to the rest of the industry. LASR is outperformed by 64.29% of its industry peers.
Industry RankSector Rank
ROA -13.58%
ROE -16.38%
ROIC N/A
ROA(3y)-12.71%
ROA(5y)-10.13%
ROE(3y)-15.46%
ROE(5y)-12.37%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of LASR (21.97%) is comparable to the rest of the industry.
LASR's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for LASR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.25%
GM growth 5Y-8.9%

8

2. Health

2.1 Basic Checks

LASR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LASR has been increased compared to 1 year ago.
The number of shares outstanding for LASR has been increased compared to 5 years ago.
There is no outstanding debt for LASR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 5.68 indicates that LASR is not in any danger for bankruptcy at the moment.
LASR has a better Altman-Z score (5.68) than 80.16% of its industry peers.
There is no outstanding debt for LASR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 5.68
ROIC/WACCN/A
WACC9.29%

2.3 Liquidity

LASR has a Current Ratio of 6.73. This indicates that LASR is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 6.73, LASR belongs to the best of the industry, outperforming 84.92% of the companies in the same industry.
A Quick Ratio of 5.14 indicates that LASR has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 5.14, LASR belongs to the best of the industry, outperforming 84.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.73
Quick Ratio 5.14

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 40.82% over the past year.
Looking at the last year, LASR shows a very negative growth in Revenue. The Revenue has decreased by -13.28% in the last year.
Measured over the past years, LASR shows a small growth in Revenue. The Revenue has been growing by 1.86% on average per year.
EPS 1Y (TTM)40.82%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q51.85%
Revenue 1Y (TTM)-13.28%
Revenue growth 3Y-1.97%
Revenue growth 5Y1.86%
Revenue growth Q2Q-8.45%

3.2 Future

The Earnings Per Share is expected to grow by 9.67% on average over the next years. This is quite good.
Based on estimates for the next years, LASR will show a quite strong growth in Revenue. The Revenue will grow by 10.47% on average per year.
EPS Next Y-60.74%
EPS Next 2Y9.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.49%
Revenue Next 2Y10.47%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

LASR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year LASR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

LASR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 112.25
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.67%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

LASR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NLIGHT INC

NASDAQ:LASR (4/25/2024, 3:30:02 PM)

After market: 11.28 0 (0%)

11.28

+0.28 (+2.55%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap533.43M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.58%
ROE -16.38%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 21.97%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 6.73
Quick Ratio 5.14
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)40.82%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-60.74%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-13.28%
Revenue growth 3Y-1.97%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y